HIGHLIGHTS
- who: Toshihide Izumida and colleagues from the Department of Surgery, Faculty of Medicine, University of Toyama, Toyama, Japan have published the research work: Acute Heart Failure in a Patient with Occult Barlow’s Disease Receiving Bevacizumab, in the Journal: Medicina 2021, 57, 998. of /2021/
- what: The existence of mitral valve regurgitation, even when sub-clinical, might be a risk of worsening heart failure during bevacizumab therapy.
SUMMARY
The association between cardiology and oncology, known as an onco-cardiology, has received great concern thus far. Several oncological medications increase the risk . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.